Munoz Benito 4
4 · PROTEOSTASIS THERAPEUTICS, INC. · Filed Feb 5, 2019
Insider Transaction Report
Form 4
Munoz Benito
See Remarks
Transactions
- Exercise/Conversion
Restricted Stock Units
2019-02-01−24,953→ 0 total→ Common Stock (24,953 underlying) - Exercise/Conversion
Common Stock
2019-02-01+24,953→ 24,953 total - Sale
Common Stock
2019-02-04$2.99/sh−9,514$28,454→ 15,439 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of PTI common stock.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and were made in order to pay the tax liability arising from the vesting of restricted stock units.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.96 to $3.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The restricted stock units vested in full on February 1, 2019.